A Study of JNJ-64281802 in Healthy Adult Participants
NCT05201937
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
JNJ-64281802
Sponsor
Janssen Research & Development, LLC